Scholars Central

Conference abstractPublished 22 Nov 2024

Advances in Artificial Pancreas Technology

Authors: Michael Rodriguez

Stanford University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Managing type 1 diabetes (T1D) requires continuous blood glucose monitoring and insulin administration. Artificial pancreas systems aim to automate this process but face challenges in accuracy and user compliance. A randomized controlled trial evaluated a novel artificial pancreas algorithm in 200 patients over six months. Outcomes included glucose variability, time-in-range metrics, and user satisfaction. The new system demonstrated superior glucose control with a 25% reduction in variability compared to standard therapy. User feedback highlighted improved quality of life and reduced mental burden. Enhanced algorithms can revolutionize T1D management, paving the way for broader adoption of artificial pancreas systems.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Endocrinology & Metabolic Syndrome.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEndocrinology & Metabolic Syndrome
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Michael Rodriguez”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels